Day One

Wednesday 20th March 2013

8.00  Registration, Coffee & Networking

8.45  Chair’s Opening Remarks

9.00  Building the Bridge to Clinical Trials in Regenerative Medicine - How do we Improve Translation?

9.30  The Cell Therapy Industry Clinical Pipeline and the Story of the Moving Hockey Stick

10.00  Reimbursement Considerations for Medical Devices: A Payor’s Perspective

10.30  Speed Networking & Morning Refreshments 

Ensuring Quality Control in the Clinic

12.00  Achieving Scaled Manufacturing of Stem Cells in Preparation for Advanced Clinical Investigations

12.30  Quality Control and Biosafety Testing of Clinical Reagents and Patient Cells

1.00  Lunch & Networking

Improving the Design of Clinical Trials

2.00 Cell Therapy Clinical Trials: Effective Trial Design

2.30  A 20 Year Perspective of Clinical Trial Development for CVD: Lessons and Directions

3.00  Designing Clinical Trials with Economic Endpoints to Achieve Regulatory Approval and Reimbursement

3.30  Afternoon Refreshments & Networking

4.00  Cost Effectiveness: Critical for Reimbursement and Investment

4.30 Achieving Regulatory Approval and Reimbursement for your Cellular Therapy Across Multiple Markets

5.00  Selecting the Most Suitable Biomarkers for your Cell Therapy Development Program

5.30  Chair’s Closing Remarks